Fig. 4.

Fully-adjusted odds ratio and 95% confidence intervals for demographic, clinical, pharmacological, and socioeconomic characteristics associated with the “decreasing”, “slow decreasing”, and “maintained” trajectories in comparison with the “discontinued” trajectory in the age group 18–64 years at the initiation of BZDR treatment. *Graphical representation of odds ratio and 95% confidence intervals for multiple initial benzodiazepines and/or z-dugs for the ‘maintained’ trajectory vs ‘discontinued’ trajectory is not visible in the figure. BZD, Benzodiazepines; BZDR, benzodiazepines and Z-drugs